Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

EOLS

Evolus (EOLS)

Evolus Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:EOLS
일자시간출처헤드라인심볼기업
2025/03/0506:44Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EOLSEvolus Inc
2025/03/0506:40Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EOLSEvolus Inc
2025/03/0506:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
2025/02/2722:00Business WireEvolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor ConferencesNASDAQ:EOLSEvolus Inc
2025/02/2022:00Business WireEvolus to Participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness SummitNASDAQ:EOLSEvolus Inc
2025/02/1822:00Business WireEvolus to Report Fourth Quarter and Year End 2024 Results on March 4, 2025NASDAQ:EOLSEvolus Inc
2025/02/1403:30Business WireEvolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid GelsNASDAQ:EOLSEvolus Inc
2025/02/0809:09Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
2025/02/0706:16Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:EOLSEvolus Inc
2025/01/2122:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
2025/01/2122:00Business WireEvolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company’s GuidanceNASDAQ:EOLSEvolus Inc
2025/01/1806:05Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
2024/12/2707:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
2024/12/2707:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
2024/12/1406:05Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
2024/11/0707:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EOLSEvolus Inc
2024/11/0706:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EOLSEvolus Inc
2024/11/0706:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
2024/11/0706:05Business WireEvolus Reports Third Quarter 2024 ResultsNASDAQ:EOLSEvolus Inc
2024/11/0121:00Business WireEvolus to Participate in Stifel 2024 Healthcare ConferenceNASDAQ:EOLSEvolus Inc
2024/11/0103:02Business WireEvolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device RegulationNASDAQ:EOLSEvolus Inc
2024/10/2921:00Business WireEvolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled ConsumersNASDAQ:EOLSEvolus Inc
2024/10/2321:00Business WireEvolus to Report Third Quarter Financial Results on November 6, 2024NASDAQ:EOLSEvolus Inc
2024/10/1211:53Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
2024/09/2810:00Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
2024/09/0710:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
2024/09/0710:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
2024/09/0621:00Business WireEvolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024NASDAQ:EOLSEvolus Inc
2024/09/0505:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
2024/08/1005:30Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
 검색 관련기사 보기:NASDAQ:EOLS